In:
Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 107, No. 12 ( 2010-12-10), p. 1503-1511
Abstract:
The rapid delayed rectifier potassium current, I Kr , which flows through the human ether-a-go-go-related (hERG) channel, is a major determinant of the shape and duration of the human cardiac action potential (APD). However, it is unknown whether the time dependency of I Kr enables it to control APD, conduction velocity (CV), and wavelength (WL) at the exceedingly high activation frequencies that are relevant to cardiac reentry and fibrillation. Objective: To test the hypothesis that upregulation of hERG increases functional reentry frequency and contributes to its stability. Methods and Results: Using optical mapping, we investigated the effects of I Kr upregulation on reentry frequency, APD, CV, and WL in neonatal rat ventricular myocyte (NRVM) monolayers infected with GFP (control), hERG ( I Kr ), or dominant negative mutant hERG G628S. Reentry frequency was higher in the I Kr -infected monolayers (21.12±0.8 Hz; n=43 versus 9.21±0.58 Hz; n=16; P 〈 0.001) but slightly reduced in G628S-infected monolayers. APD 80 in the I Kr -infected monolayers was shorter ( 〉 50%) than control during pacing at 1 to 5 Hz. CV was similar in both groups at low frequency pacing. In contrast, during high-frequency reentry, the CV measured at varying distances from the center of rotation was significantly faster in I Kr -infected monolayers than controls. Simulations using a modified NRVM model predicted that rotor acceleration was attributable, in part, to a transient hyperpolarization immediately following the AP. The transient hyperpolarization was confirmed experimentally. Conclusions: hERG overexpression dramatically accelerates reentry frequency in NRVM monolayers. Both APD and WL shortening, together with transient hyperpolarization, underlies the increased rotor frequency and stability.
Type of Medium:
Online Resource
ISSN:
0009-7330
,
1524-4571
DOI:
10.1161/CIRCRESAHA.110.232470
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2010
detail.hit.zdb_id:
1467838-X
Permalink